ICON plc (ICLR) PT Raised to $383 at Truist Securities

Go back to ICON plc (ICLR) PT Raised to $383 at Truist Securities

ICON plc (ICLR) PT Lowered to $368 at Baird

July 26, 2024 6:23 AM EDT

Baird analyst Eric Coldwell lowered the price target on ICON plc (NASDAQ: ICLR) to $368.00 (from $376.00) while maintaining a Outperform rating.

The analyst comments "Reiterate Outperform rating, new $368 price target. Q2 rattled the market with some imperfections against high expectations, but this is not... More

ICON plc (ICLR) PT Lowered to $380 at Jefferies

July 26, 2024 5:34 AM EDT

Jefferies analyst David Windley lowered the price target on ICON plc (NASDAQ: ICLR) to $380.00 (from $390.00) while maintaining a Buy rating.

The analyst comments "While mgt's "body language" at our June Conf suggested a... More

ICON plc (ICLR) PT Lowered to $350 at Barclays

July 26, 2024 3:35 AM EDT

Barclays analyst Luke Sergott lowered the price target on ICON plc (NASDAQ: ICLR) to $350.00 (from $355.00) while maintaining a Overweight rating.... More

ICON plc (ICLR) Tops Q2 EPS by 8c

July 24, 2024 4:21 PM EDT

ICON plc (NASDAQ: ICLR) reported Q2 EPS of $3.75, $0.08 better than the analyst estimate of $3.67. Revenue for the quarter came in at $2.12 billion versus the consensus estimate of $2.14 billion.

For earnings history and earnings-related data on ICON plc (ICLR) click here.

... More

ICON plc (ICLR) Announces Board Changes

July 24, 2024 6:01 AM EDT

ICON plc (NASDAQ: ICLR), a world-leading healthcare intelligence and clinical research organization, today announced that all resolutions at the Annual General Meeting of the company (AGM) held on July 23, 2024 were duly passed by shareholders. ICON also confirmed that following the conclusion of the company's AGM, Joan Garahy retired as a... More